The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) . The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities. It provides deep subject-matter leadership and enterprise-level judgement to ensure potential partnerships and acquisitions advance CSL’s portfolio impa…